Epilog Partners snaps up Care Connectors Medical Group

TAGS

Epilog Partners, a private equity platform specialising in healthcare investments, has announced a significant acquisition of Care Connectors Medical Group. This majority recapitalization deal includes substantial rollover investments from the company’s founders and co-investment from HealthQuest Capital, Echo Health Ventures, and Blue Venture Fund. The terms of the recapitalization were not disclosed.

Headquartered in Newport Beach, California, Care Connectors Medical Group is a prominent player in value-based care enablement. The company partners with health plans and risk-bearing providers to enhance prospective risk adjustment, quality improvement, and care coordination. Offering both in-home (in-person and virtual) and community-based solutions (including primary care and mobile clinics), Care Connectors is at the forefront of delivering tailored healthcare services.

See also  HistoSonics secures $102m in blockbuster funding to transform liver cancer treatment forever

Strategic Partnership and Future Growth

Nilay Shah, Co-founder and Chief Executive Officer of Care Connectors Medical Group, highlighted the significance of the partnership with Epilog Partners. Shah noted that Care Connectors leverages its experiences and AI-enabled software platform to deliver solutions that address unique customer needs. Shah expressed enthusiasm about the partnership, citing Epilog Partners’ successful track record with high-growth companies in the value-based care sector and their understanding of the company-building journey.

Chris Price, Founder and Managing Partner at Epilog Partners, emphasised Care Connectors’ ability to engage challenging and non-compliant patients. Price pointed out that the company’s role as an extension of primary care physicians and health plans is increasingly crucial for achieving optimal outcomes in a changing regulatory and care delivery environment. He expressed excitement about working with Care Connectors and the valuable contributions of the co-investors.

See also  HistoSonics secures $102m in blockbuster funding to transform liver cancer treatment forever

Kyle Gay, Principal at Epilog Partners, noted that Care Connectors represents the firm’s third platform investment and reflects their commitment to investing in tech-enabled payer and provider services. Gay highlighted Epilog’s ongoing investments in CareMetx, a leading biopharma hub services company, and the successful exit from ReCept, a specialty pharmacy managed services company, to Omnicell.

Transaction Details and Advisors

The acquisition involved several key advisory firms. Gibson, Dunn & Crutcher and Holland & Knight represented Epilog Partners in the transaction, while BMO Sponsor Finance led the financing. Care Connectors Medical Group was advised by Bailey & Company and Sheppard Mullin.

See also  HistoSonics secures $102m in blockbuster funding to transform liver cancer treatment forever

Care Connectors Medical Group, founded in 2018 by Nilay Shah, Dr. Vinod Kannarkat, and Andrew Lam, has established itself as a leading force in value-based care. The company’s focus on managing risk adjustment, quality improvement, and care coordination is vital for health plans and risk-bearing providers. Epilog Partners, with a focus on tech-enabled services and software, continues to expand its portfolio, leveraging a research-centric, thesis-driven approach to guide its investment strategy.


Discover more from Business-News-Today.com

Subscribe to get the latest posts sent to your email.

CATEGORIES
TAGS
Share This